Aggregation of blood platelets by biogenic amines and its inhibition by antiadrenergic and antiserotoninergic agents.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive; D001679:Biogenic Amines / Q000494:pharmacology*; D003720:Densitometry; D003864:Depression, Chemical; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D013565:Sympatholytics / Q000494:pharmacology*; D013710:Tendons; D013997:Time Factors; D014020:Tissue Extracts / Q000494:pharmacology; D015016:Yohimbine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D001679:Biogenic Amines; D012702:Serotonin Antagonists; D013565:Sympatholytics; D014020:Tissue Extracts; D015016:Yohimbine; D012701:Serotonin; D003983:Dibenzylchlorethamine; D008238:Lysergic Acid Diethylamide; D011433:Propranolol; D010208:Papaverine; D007545:Isoproterenol; D004878:Ergotamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine